Anti-obesity effects of Wumeishanzhayin: an integrated lipidomics and transcriptomics study
WMSZY significantly reduces body weight gain and ameliorates glucose and lipid metabolic disorders in HFHF diet-induced mice. Its anti-obesity effect is likely due to the regulation of lipid metabolism <i>via</i> the AMPK/CPT-1 signaling pathway.
Authors
- Xiao Huang (ORCID: https://orcid.org/0000-0002-3867-900X)
- Chunling Liao
- Qingman He
- Jinhui Wang (ORCID: https://orcid.org/0000-0001-8340-717X)
- Yong Zhang (ORCID: https://orcid.org/0000-0003-0513-8941)
- Bo Peng (ORCID: https://orcid.org/0000-0001-9411-716X)
- Mei Zhao
- Sijie Dang
Institutions
- Leshan Normal University (CN)
- Chengdu University (CN)
- Sichuan Academy of Traditional Chinese Medicine (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.3389/fphar.2025.1697683
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00